Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor(FTI) to induce efficient apoptosis of human cancer cell lines.

EDAMATSU H; GAU C-L; NEMOTO T; GUO L; TAMANOI F

Art

J-GLOBAL ID：200902100054228950 Reference number：00A0942573

Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor(FTI) to induce efficient apoptosis of human cancer cell lines.

Cdk阻害剤であるロスコビチン及びオロモウシンはヒト癌細胞系の効率的アポトーシスを誘導するファルネシルトランスフェラーゼ阻害剤(FTI)と相乗作用する

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=00A0942573&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=00A0942573&from=J-GLOBAL&jstjournalNo=T0406A") }}

Author (5)： , , , ,
Material：
Volume： 19 Issue： 27 Page： 3059-3068 Publication year： Jun. 22, 2000
JST Material Number： T0406A ISSN： 0950-9232 Document type： Article
Article type：原著論文 Country of issue： United States (USA) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=00A0942573&from=J-GLOBAL&jstjournalNo=T0406A") }}

Basic research of antitumor(=antineoplastic)drugs , Cell physiology in general , Enzyme in general

, ,

, , , , , , , ,

Return to Previous Page